
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17889818
[patent_doc_number] => 11452765
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => Sequence specific antimicrobials
[patent_app_type] => utility
[patent_app_number] => 17/581614
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 10633
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581614 | Sequence specific antimicrobials | Jan 20, 2022 | Issued |
Array
(
[id] => 17595325
[patent_doc_number] => 20220144898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING CANCER USING PEPTIDE NUCLEIC ACID-BASED AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/581467
[patent_app_country] => US
[patent_app_date] => 2022-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/581467 | METHODS AND COMPOSITIONS FOR TREATING CANCER USING PEPTIDE NUCLEIC ACID-BASED AGENTS | Jan 20, 2022 | Pending |
Array
(
[id] => 19624318
[patent_doc_number] => 12163125
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-10
[patent_title] => Engineered class 2 type V CRISPR systems
[patent_app_type] => utility
[patent_app_number] => 17/572208
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 60
[patent_figures_cnt] => 77
[patent_no_of_words] => 126604
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17572208
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/572208 | Engineered class 2 type V CRISPR systems | Jan 9, 2022 | Issued |
Array
(
[id] => 17533899
[patent_doc_number] => 20220112508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLS
[patent_app_type] => utility
[patent_app_number] => 17/555395
[patent_app_country] => US
[patent_app_date] => 2021-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56248
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555395
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555395 | INSTRUMENTS, MODULES, AND METHODS FOR IMPROVED DETECTION OF EDITED SEQUENCES IN LIVE CELLS | Dec 17, 2021 | Abandoned |
Array
(
[id] => 18329526
[patent_doc_number] => 11634755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-04-25
[patent_title] => Crispr enzymes and systems
[patent_app_type] => utility
[patent_app_number] => 17/554333
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 345
[patent_figures_cnt] => 388
[patent_no_of_words] => 206996
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554333
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554333 | Crispr enzymes and systems | Dec 16, 2021 | Issued |
Array
(
[id] => 18590406
[patent_doc_number] => 11739290
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-29
[patent_title] => Instruments, modules, and methods for improved detection of edited sequences in live cells
[patent_app_type] => utility
[patent_app_number] => 17/555336
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 52
[patent_figures_cnt] => 78
[patent_no_of_words] => 56241
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17555336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/555336 | Instruments, modules, and methods for improved detection of edited sequences in live cells | Dec 16, 2021 | Issued |
Array
(
[id] => 18666554
[patent_doc_number] => 11773432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => CRISPR enzymes and systems
[patent_app_type] => utility
[patent_app_number] => 17/554314
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 345
[patent_figures_cnt] => 388
[patent_no_of_words] => 206655
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17554314
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/554314 | CRISPR enzymes and systems | Dec 16, 2021 | Issued |
Array
(
[id] => 19381311
[patent_doc_number] => 20240271181
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => METHODS FOR DETECTING HOMOGENOUS TARGETS IN A POPULATION WITH NEXT GENERATION SEQUENCING
[patent_app_type] => utility
[patent_app_number] => 18/266692
[patent_app_country] => US
[patent_app_date] => 2021-12-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15044
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18266692
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/266692 | METHODS FOR DETECTING HOMOGENOUS TARGETS IN A POPULATION WITH NEXT GENERATION SEQUENCING | Dec 9, 2021 | Pending |
Array
(
[id] => 18085766
[patent_doc_number] => 11535887
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Methods for spatial analysis using targeted RNA depletion
[patent_app_type] => utility
[patent_app_number] => 17/546625
[patent_app_country] => US
[patent_app_date] => 2021-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 38
[patent_no_of_words] => 36776
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17546625
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/546625 | Methods for spatial analysis using targeted RNA depletion | Dec 8, 2021 | Issued |
Array
(
[id] => 17482594
[patent_doc_number] => 20220090098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => GENETICALLY ENGINEERED VIBRIO SP. AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/541163
[patent_app_country] => US
[patent_app_date] => 2021-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17541163
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/541163 | GENETICALLY ENGINEERED VIBRIO SP. AND USES THEREOF | Dec 1, 2021 | Pending |
Array
(
[id] => 17474177
[patent_doc_number] => 20220081681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => ENGINEERED PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/533997
[patent_app_country] => US
[patent_app_date] => 2021-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 155522
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533997
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533997 | Engineered proteins | Nov 22, 2021 | Issued |
Array
(
[id] => 17930201
[patent_doc_number] => 20220325326
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-13
[patent_title] => EVALUATION OF CAS9 MOLECULE/GUIDE RNA MOLECULE COMPLEXES
[patent_app_type] => utility
[patent_app_number] => 17/533007
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48658
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17533007
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/533007 | EVALUATION OF CAS9 MOLECULE/GUIDE RNA MOLECULE COMPLEXES | Nov 21, 2021 | Pending |
Array
(
[id] => 17460677
[patent_doc_number] => 20220073982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => METHODS AND SYSTEMS FOR DETERMINING A PREGNANCY-RELATED STATE OF A SUBJECT
[patent_app_type] => utility
[patent_app_number] => 17/522425
[patent_app_country] => US
[patent_app_date] => 2021-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38241
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 147
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17522425
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/522425 | Methods and systems for determining a pregnancy-related state of a subject | Nov 8, 2021 | Issued |
Array
(
[id] => 17541186
[patent_doc_number] => 11306299
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-19
[patent_title] => Simultaneous multiplex genome editing in yeast
[patent_app_type] => utility
[patent_app_number] => 17/518556
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 38
[patent_no_of_words] => 32404
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 269
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17518556
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/518556 | Simultaneous multiplex genome editing in yeast | Nov 2, 2021 | Issued |
Array
(
[id] => 17414329
[patent_doc_number] => 20220049233
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => NOVEL MAD NUCLEASES
[patent_app_type] => utility
[patent_app_number] => 17/518481
[patent_app_country] => US
[patent_app_date] => 2021-11-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11061
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17518481
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/518481 | NOVEL MAD NUCLEASES | Nov 2, 2021 | Pending |
Array
(
[id] => 17548482
[patent_doc_number] => 20220119823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => Univariant Extrinsic Initiator Control System For Microbes And An In Vitro Assembly Of Large Recombinant DNA Molecules From Multiple Components
[patent_app_type] => utility
[patent_app_number] => 17/453238
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21882
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17453238
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/453238 | Univariant Extrinsic Initiator Control System For Microbes And An In Vitro Assembly Of Large Recombinant DNA Molecules From Multiple Components | Nov 1, 2021 | Pending |
Array
(
[id] => 17890910
[patent_doc_number] => 11453867
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-27
[patent_title] => CRISPR DNA targeting enzymes and systems
[patent_app_type] => utility
[patent_app_number] => 17/505578
[patent_app_country] => US
[patent_app_date] => 2021-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 38865
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17505578
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/505578 | CRISPR DNA targeting enzymes and systems | Oct 18, 2021 | Issued |
Array
(
[id] => 17579130
[patent_doc_number] => 20220135985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
[patent_app_type] => utility
[patent_app_number] => 17/503928
[patent_app_country] => US
[patent_app_date] => 2021-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51296
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17503928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/503928 | CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | Oct 17, 2021 | Pending |
Array
(
[id] => 17505196
[patent_doc_number] => 20220098298
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => COMPOSITIONS AND METHODS FOR IMPROVING HEALTH THROUGH MODULATING CALHM2
[patent_app_type] => utility
[patent_app_number] => 17/450998
[patent_app_country] => US
[patent_app_date] => 2021-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17450998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/450998 | COMPOSITIONS AND METHODS FOR IMPROVING HEALTH THROUGH MODULATING CALHM2 | Oct 14, 2021 | Pending |
Array
(
[id] => 18817795
[patent_doc_number] => 20230392135
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-07
[patent_title] => ENGINEERED CAS ENDONUCLEASE VARIANTS FOR IMPROVED GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 18/248933
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47663
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18248933
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/248933 | ENGINEERED CAS ENDONUCLEASE VARIANTS FOR IMPROVED GENOME EDITING | Oct 12, 2021 | Pending |